- Evaluation of E1B-mutant Replicating Adenoviruses for Cancer Gene Therapy
-
Kim JS, Kim JH, Lee HR, Jung KC, Yun CO
- KMID: 2166225
- Cancer Res Treat.
- 2001 Dec;33(6):500-511.
PURPOSE: Gene-attenuated replication-competent adenoviruses are emerging as a promising new modality for the treatment of cancer. In an effort to continually improve upon cancer gene therapy, we have modified gene-... -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcoma and Sarcomatous Metaplastic Carcinoma of the Breast
-
Yu SH, Noh WC, Bang HY, Hwang DY, Choi DW, Lee JI, Paik NS, Moon NM, Jung JH
- KMID: 2166214
- Cancer Res Treat.
- 2001 Dec;33(6):463-468.
PURPOSE: Primary sarcoma and SMC (sarcomatous metaplastic carcinoma) of the breast are very rare tumors, accounting for less than 1% of all breast malignancies. There are many controversies concerning the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
-
Kim BS, Oh DY, Joh YH, Kim DY, Kim JH, Lee SH, Lee DH, Kim TY, Heo DS, Bang YJ, Kim NK
- KMID: 2166217
- Cancer Res Treat.
- 2001 Dec;33(6):469-473.
PURPOSE: To evaluate the efficacy and toxicity of combination chemotherapy with low-dose paclitaxel and cisplatin in patients with advanced non-small cell lung cancer. MATERIALS AND METHODS: Chemotherapy-naive patients with unresectable, pathologically... -
- CITED
-
- Close
- SHARE
-
- Close
- Proportion of Death Certificate Only Cases and Its Related Factors, Kwangju Cancer Registry (KCR)
-
Lee SJ, Shin MH, Kim SY, Park KS, Kim YJ, Hwang TJ, Choi JS
- KMID: 2166226
- Cancer Res Treat.
- 2001 Dec;33(6):512-519.
PURPOSE: To ascertain the factors associated with the proportion of death certificate only (DCO) cases contained in the Kwangju Cancer Registry (KCR) that are not as yet in the good... -
- CITED
-
- Close
- SHARE
-
- Close
- Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregional Esophageal Cancer
-
Lee GW, Kang JH, Kim HG, Hwang IG, Shim KS, Kim SH, Lee WS, Jung WT, Lee OJ, Cho JH, Jang JS, Chae KY, Lee JS
- KMID: 2166223
- Cancer Res Treat.
- 2001 Dec;33(6):489-494.
PURPOSE: The object of this study is to evaluate the efficacy and toxicity of induction chemotherapy followed by concomitant chemoradiotherapy in locoregional esophageal cancer. MATERIALS AND METHODS: Between December 1992 and... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Pre- and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
-
Sohn JH, Rha SY, Jeung HC, Shin HJ, Goo YS, Chung HC, Yang WI, Hahn SB, Shin KH, Min JS, Kim BS, Roh JK, Jang WI
- KMID: 2166227
- Cancer Res Treat.
- 2001 Dec;33(6):520-526.
PURPOSE: We evaluated the treatment efficacy including survival and recurrence, and factors associated with recurrence in osteosarcoma patients treated with preoperative chemotherapy, surgery, and adjuvant chemotherapy. MATERIALS AND METHODS: Forty nine... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features of Neuroendocrine Lung Cancer
-
Kim EK, Jang GD, Suh CW, Kim SW, Lee SD, Kim WS, Lee JS, Lee HJ, Lee IC
- KMID: 2166219
- Cancer Res Treat.
- 2001 Dec;33(6):474-477.
PURPOSE: This study was performed to investigate the clinical features of neuroendocrine lung cancer. MATERIALS AND METHODS: We performed a retrospective review of the histopathology and clinical information of 21 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Reoperation of Recurrent Gastric Cancer
-
Park SM, Lee CH, Park CH, Kim W, Ahn CJ, Lim GW, Park WB, Kim SN, Kim IC
- KMID: 2166221
- Cancer Res Treat.
- 2001 Dec;33(6):478-482.
PURPOSE: The aim of this study was to evaluate the outcome of reoperation in recurrent gastric cancers. MATERIALS AND METHODS: We conducted a retrospective analysis of 86 patients who underwent reoperation... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Genexol(R) (paclitaxel) in Metastatic Breast Cancer
-
Jung JY, Jeong HC, Yoon SS, Lee JH, Kim JS, Kim HJ, Kim KH, Park JO, Lee WS, Heo DS, Bang YJ, Kim NK
- KMID: 2166210
- Cancer Res Treat.
- 2001 Dec;33(6):451-457.
PURPOSE: Paclitaxel is a very effective agent in the treatment of breast cancer. Samyang Corporation has developed its own process to produce paclitaxel in a large volume using plant cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutation of Ha-ras Oncogene in Rat Salivary Gland Tumors Induced by DMBA
-
Yeh BI, Han DP, Sohn JH, Yoon JH, Lee HA, Chang SJ, Kong ID, Kim HW, Choi JW
- KMID: 2166224
- Cancer Res Treat.
- 2001 Dec;33(6):495-499.
PURPOSE: The incidence of salivary gland tumor is approximately 2% among all head and neck tumors, of which malignant cases account for only about 5%. Much research has been performed... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Peripheral Blood CEA mRNA Expression in Gastric Cancer Patients Underwent Curative Resection
-
Seo JH, Park SH, Bak CW, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS, Mok YJ, Kim JS, Han SA, Yoon JI
- KMID: 2166222
- Cancer Res Treat.
- 2001 Dec;33(6):483-488.
PURPOSE: Recent advances in molecular technology have made it possible to detect small numbers of circulating tumor cells in the peripheral blood or bone marrow. Carcinoembryonic antigen (CEA) is an... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Analysis of Phyllodes Tumor of the Breast
-
Han SH, Lee WG, Cha KH, Lee TH, Shin DB, Ha SY, Park HG
- KMID: 2166212
- Cancer Res Treat.
- 2001 Dec;33(6):458-462.
PURPOSE: Phyllodes tumors are fibroepithelial mammary lesions that tend to behave in a benign fashion but may undergo sarcomatous transformation. They account for 0.3 to 0.5 percent of all breast... -
- CITED
-
- Close
- SHARE
-
- Close
